• LAST PRICE
    0.0000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    --- / 0.0000
  • Day Range
    ---
  • 52 Week Range
    Low 0.0000
    High 0.0000
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesACGJ
ACI Global Corp
320.0
0.0x
---
United StatesGNLKQ
Genelink Inc
2.7K
0.0x
---
United StatesDPWW
Diego Pellicer Worldwide Inc
26.1K
0.0x
---
United StatesARBH
Arboreta Healthcare Inc
13.7K
---
---
United StatesKONEF
Wellbeing Digital Sciences Inc
130.0
0.0x
---
United StatesERUC
ER Urgent Care Holdings Inc
40.0
0.0x
---
As of 2024-11-08

Company Information

ACI Global Corp., formerly Par Advance Technologies Corp., a clinical-stage biopharmaceutical company engaged in the development of natural and novel peptides for the treatment or prevention of infections due to multi-drug resistant bacteria and fungi. The Company's drug candidates are proprietary synthetic and natural peptides (small proteins). Antecedents for these compounds occur in nature as part of the immune system of animals, insects and plants. Generally, the peptides bind to and kill harmful microorganisms and cancer cells. P113D, the Company's product candidate for cystic fibrosis, has been awarded Orphan Drug designation by the United States Food and Drug Administration (FDA). Demegen is also developing a novel, synthetic antimicrobial peptide in a rinse formulation for the treatment and prevention of oral candidiasis. The Company's peptide technology can also be used to prevent serious damage to crops caused by fungal and bacterial diseases.

Contact Information

Headquarters
16 North Water Street, #106GREENWICH, CT, United States 06830
Phone
203-987-5356
Fax
---

Executives

Chairman of the Board, President, Chief Financial Officer, Secretary
Richard Ekstrom
Director
Joseph Lovett

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$320.00
Revenue (TTM)
$1.2M
Shares Outstanding
320.9M
ACI Global Corp does not pay a dividend.
Beta
---
EPS
$-1.10
Book Value
$-2.75
P/E Ratio
0.0x
Price/Sales (TTM)
0.0
Price/Cash Flow (TTM)
---
Operating Margin
-92.99%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.